The "smile-and-fill" injection technique: A dynamic approach to midface volumization

Audrey S. Wang, Olubukola Babalola, Jared Jagdeo

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Injectable poly-L-lactic acid (PLLA) is a biodegradable, biocompatible, synthetic polymer that acts as a scaffold to promote collagen formation and is FDA-approved for the correction of facial lipoatrophy in patients with human immunodeficiency virus (HIV) infection. The safety and efficacy of injectable PLLA for the treatment of HIV-associated facial lipoatrophy has been demonstrated in clinical studies and is accompanied by improvement in patient quality of life. Volumization of the mid-face is regarded as complex. The importance of respecting patient mid-face differences at rest and in motion was highlighted in a study that demonstrated effectiveness of silicone microdroplets (0.01 mL) in a depot manner to treat HIV patients with facial lipoatrophy. One of the challenges of facial volume rejuvenation with these techniques is preserving and enhancing dynamic facial movements after treatment. To address this challenge, we developed an injection technique termed "smile-and-fill. " In this case series, we describe three patients treated by this technique to restore the malar aspect of the mid-face with improvement several months post-treatment.

Original languageEnglish (US)
Pages (from-to)288-290
Number of pages3
JournalJournal of Drugs in Dermatology
Volume13
Issue number3
StatePublished - 2014

Fingerprint

Injections
HIV
Rejuvenation
Silicones
Virus Diseases
Polymers
Collagen
Therapeutics
Quality of Life
Safety
poly(lactic acid)

ASJC Scopus subject areas

  • Dermatology
  • Medicine(all)

Cite this

The "smile-and-fill" injection technique : A dynamic approach to midface volumization. / Wang, Audrey S.; Babalola, Olubukola; Jagdeo, Jared.

In: Journal of Drugs in Dermatology, Vol. 13, No. 3, 2014, p. 288-290.

Research output: Contribution to journalArticle

@article{4208a438172c4fe2980f618cb18e5bb7,
title = "The {"}smile-and-fill{"} injection technique: A dynamic approach to midface volumization",
abstract = "Injectable poly-L-lactic acid (PLLA) is a biodegradable, biocompatible, synthetic polymer that acts as a scaffold to promote collagen formation and is FDA-approved for the correction of facial lipoatrophy in patients with human immunodeficiency virus (HIV) infection. The safety and efficacy of injectable PLLA for the treatment of HIV-associated facial lipoatrophy has been demonstrated in clinical studies and is accompanied by improvement in patient quality of life. Volumization of the mid-face is regarded as complex. The importance of respecting patient mid-face differences at rest and in motion was highlighted in a study that demonstrated effectiveness of silicone microdroplets (0.01 mL) in a depot manner to treat HIV patients with facial lipoatrophy. One of the challenges of facial volume rejuvenation with these techniques is preserving and enhancing dynamic facial movements after treatment. To address this challenge, we developed an injection technique termed {"}smile-and-fill. {"} In this case series, we describe three patients treated by this technique to restore the malar aspect of the mid-face with improvement several months post-treatment.",
author = "Wang, {Audrey S.} and Olubukola Babalola and Jared Jagdeo",
year = "2014",
language = "English (US)",
volume = "13",
pages = "288--290",
journal = "Journal of Drugs in Dermatology",
issn = "1545-9616",
publisher = "Journal of Drugs in Dermatology",
number = "3",

}

TY - JOUR

T1 - The "smile-and-fill" injection technique

T2 - A dynamic approach to midface volumization

AU - Wang, Audrey S.

AU - Babalola, Olubukola

AU - Jagdeo, Jared

PY - 2014

Y1 - 2014

N2 - Injectable poly-L-lactic acid (PLLA) is a biodegradable, biocompatible, synthetic polymer that acts as a scaffold to promote collagen formation and is FDA-approved for the correction of facial lipoatrophy in patients with human immunodeficiency virus (HIV) infection. The safety and efficacy of injectable PLLA for the treatment of HIV-associated facial lipoatrophy has been demonstrated in clinical studies and is accompanied by improvement in patient quality of life. Volumization of the mid-face is regarded as complex. The importance of respecting patient mid-face differences at rest and in motion was highlighted in a study that demonstrated effectiveness of silicone microdroplets (0.01 mL) in a depot manner to treat HIV patients with facial lipoatrophy. One of the challenges of facial volume rejuvenation with these techniques is preserving and enhancing dynamic facial movements after treatment. To address this challenge, we developed an injection technique termed "smile-and-fill. " In this case series, we describe three patients treated by this technique to restore the malar aspect of the mid-face with improvement several months post-treatment.

AB - Injectable poly-L-lactic acid (PLLA) is a biodegradable, biocompatible, synthetic polymer that acts as a scaffold to promote collagen formation and is FDA-approved for the correction of facial lipoatrophy in patients with human immunodeficiency virus (HIV) infection. The safety and efficacy of injectable PLLA for the treatment of HIV-associated facial lipoatrophy has been demonstrated in clinical studies and is accompanied by improvement in patient quality of life. Volumization of the mid-face is regarded as complex. The importance of respecting patient mid-face differences at rest and in motion was highlighted in a study that demonstrated effectiveness of silicone microdroplets (0.01 mL) in a depot manner to treat HIV patients with facial lipoatrophy. One of the challenges of facial volume rejuvenation with these techniques is preserving and enhancing dynamic facial movements after treatment. To address this challenge, we developed an injection technique termed "smile-and-fill. " In this case series, we describe three patients treated by this technique to restore the malar aspect of the mid-face with improvement several months post-treatment.

UR - http://www.scopus.com/inward/record.url?scp=84896372016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896372016&partnerID=8YFLogxK

M3 - Article

C2 - 24595573

AN - SCOPUS:84896372016

VL - 13

SP - 288

EP - 290

JO - Journal of Drugs in Dermatology

JF - Journal of Drugs in Dermatology

SN - 1545-9616

IS - 3

ER -